Contact this trialFirst, we need to learn more about you.
Immunotherapy
BMS-986301 + Immunotherapy for Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial is testing a new drug called BMS-986301, either alone or with two other drugs, nivolumab and ipilimumab. It targets cancer patients whose disease did not improve with standard treatments. The drugs aim to boost the body's natural defenses to better identify and destroy cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service